2,6-dimethyl-1,4-benzoquinone and Lung Neoplasms

2,6-dimethyl-1,4-benzoquinone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, Z; Kim, DJ; Laster, K; Xie, X; Zu, X	1

Other Studies

1 other study(ies) available for 2,6-dimethyl-1,4-benzoquinone and Lung Neoplasms

Article	Year
2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells. Journal of pharmacological sciences, 2021, Volume: 145, Issue:3 Topics: Antineoplastic Agents; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases	2021

Article

Year

2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.

Journal of pharmacological sciences, 2021, Volume: 145, Issue:3

Topics: Antineoplastic Agents; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2021